IL326884A - סונובינופ לשימוש בשיטה לטיפול בהפרעת שימוש באלכוהול - Google Patents

סונובינופ לשימוש בשיטה לטיפול בהפרעת שימוש באלכוהול

Info

Publication number
IL326884A
IL326884A IL326884A IL32688426A IL326884A IL 326884 A IL326884 A IL 326884A IL 326884 A IL326884 A IL 326884A IL 32688426 A IL32688426 A IL 32688426A IL 326884 A IL326884 A IL 326884A
Authority
IL
Israel
Prior art keywords
human subject
compound
alcohol
administered
disclosure
Prior art date
Application number
IL326884A
Other languages
English (en)
Inventor
Garth Whiteside
Stephen Harris
Valentine Pascale
Nelson Sessler
Original Assignee
Purdue Pharma Lp
Garth Whiteside
Stephen Harris
Valentine Pascale
Nelson Sessler
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Pharma Lp, Garth Whiteside, Stephen Harris, Valentine Pascale, Nelson Sessler filed Critical Purdue Pharma Lp
Publication of IL326884A publication Critical patent/IL326884A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL326884A 2023-10-19 2024-10-18 סונובינופ לשימוש בשיטה לטיפול בהפרעת שימוש באלכוהול IL326884A (he)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202363544858P 2023-10-19 2023-10-19
US202463670481P 2024-07-12 2024-07-12
PCT/US2024/052074 WO2025085818A1 (en) 2023-10-19 2024-10-18 Sunobinop for use in method of treating alcohol use disorder

Publications (1)

Publication Number Publication Date
IL326884A true IL326884A (he) 2026-04-01

Family

ID=93376261

Family Applications (1)

Application Number Title Priority Date Filing Date
IL326884A IL326884A (he) 2023-10-19 2024-10-18 סונובינופ לשימוש בשיטה לטיפול בהפרעת שימוש באלכוהול

Country Status (6)

Country Link
KR (1) KR20260093367A (he)
CN (1) CN122206440A (he)
AU (1) AU2024364388A1 (he)
IL (1) IL326884A (he)
MX (1) MX2026003321A (he)
WO (1) WO2025085818A1 (he)

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3536809A (en) 1969-02-17 1970-10-27 Alza Corp Medication method
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4008719A (en) 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
IE58110B1 (en) 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US5073543A (en) 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
IT1229203B (it) 1989-03-22 1991-07-25 Bioresearch Spa Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
US5120548A (en) 1989-11-07 1992-06-09 Merck & Co., Inc. Swelling modulated polymeric drug delivery device
US5733566A (en) 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
US5698155A (en) 1991-05-31 1997-12-16 Gs Technologies, Inc. Method for the manufacture of pharmaceutical cellulose capsules
US5580578A (en) 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5591767A (en) 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
IT1270594B (it) 1994-07-07 1997-05-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
US6572891B1 (en) 1999-10-23 2003-06-03 Alkaloid Ad Sublingual oral dosage form
AR037211A1 (es) * 2001-11-07 2004-10-27 Schering Corp Derivados de heteroarilo como ligandos superiores para el receptor de nociceptina orl-1
JP4739217B2 (ja) 2003-05-07 2011-08-03 サムヤン コーポレイション 速く溶ける錠剤を製造するための高可塑性顆粒
CA2664315C (en) 2006-09-15 2016-01-19 Echo Pharmaceuticals B.V. Dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances
EP2254556A2 (en) 2008-03-11 2010-12-01 Takeda Pharmaceutical Company Limited Orally-disintegrating solid preparation
RS52590B2 (sr) * 2008-07-21 2018-05-31 Purdue Pharma Lp Jedinjenja tipa supstituisanog hinoksalina sa premošćenim piperidinom i njihova upotreba
JOP20190008A1 (ar) 2016-07-26 2019-01-24 Purdue Pharma Lp علاج ومنع اضطرابات النوم
MX2020007817A (es) 2018-01-24 2020-09-25 Purdue Pharma Lp Prevención y tratamiento del trastorno del sueño.
EP3917621A1 (en) 2019-01-31 2021-12-08 Purdue Pharma LP Polymorphic forms of a substituted-quinoxaline-type bridged-piperidine compound

Also Published As

Publication number Publication date
KR20260093367A (ko) 2026-06-19
AU2024364388A1 (en) 2026-03-19
WO2025085818A1 (en) 2025-04-24
WO2025085818A9 (en) 2026-02-19
CN122206440A (zh) 2026-06-12
MX2026003321A (es) 2026-05-04

Similar Documents

Publication Publication Date Title
GB2609883B (en) Apparatus and method for additive manufacturing by ultra-high-speed laser cladding
GB202510199D0 (en) Apparatus and method for microalgae-microorganism synergistic treatment of aquaculture effluent
EP4164628A4 (en) COMPOSITION AND METHOD FOR THE TREATMENT OF CHRONIC PAIN
GB202408204D0 (en) Method and apparatus for treating myofascial points
ZA202401094B (en) Compounds that inhibit pi3k isoform alpha and methods for treating cancer
IL307532A (he) אטומייזר לטיפול במים ושיטה לשימוש בו
GB2620747B (en) Method and apparatus for speech enhancement
IL325649A (he) שיטה לטיפול בדיכאון באמצעות סלטורקסנט
IL320743A (he) שיטה לטיפול בסרטן הערמונית
CA3306214A1 (en) Sunobinop for use in method of treating alcohol use disorder
GB202504565D0 (en) Method and apparatus to perform section milling
EP4436574A4 (en) METHODS OF USING RARY AGONISTS FOR CANCER TREATMENT
IL326065A (he) שיטות לטיפול במצבים רפואיים ומחלות
KR102652947B9 (ko) 수처리 시스템 및 수처리 방법
EP4499007A4 (en) DEVICES AND METHODS FOR TREATING TINNITUS
EP4282413A4 (en) COMPOSITION AND METHOD FOR TREATING TUMORS
EP4518861A4 (en) COMPOSITION AND METHOD OF CANCER TREATMENT
HK40120772A (en) Polymorph forms of aticaprant for use in treating major depressive disorder
GB202400646D0 (en) Improvements to polishing and/or machining apparatus and method
GB202004548D0 (en) Composition for treating alcohol hangover
GB202211482D0 (en) Apparatus and method for catergorising wines
GB202009297D0 (en) Method and apparatus for improvements to gene therapy
GB202219339D0 (en) System and method for wet treatment of component
GB202004412D0 (en) Method and apparatus for improvements to gene therapy
GB202405142D0 (en) Methods and compounds for treating inflammation